ANDA 77028, held by Actavis Elizabeth. Cilostazol.
As of Nov 16, 2026, ANDA 77028 (Cilostazol), held by Actavis Elizabeth, was first approved by FDA on Nov 26, 2004, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 26, 2004 | Original application | Approved | None posted |
| Cilostazol100MG · tablet; oral | Cilostazol | Rx |
| Cilostazol100MG · tablet;oral | Cilostazol | Discontinued |
| Jul 19, 2018 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 26, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters